ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 177 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q4 2016. The put-call ratio across all filers is 0.97 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $1,533,000 | +26.6% | 21,614 | -12.7% | 0.05% | +22.7% |
| Q2 2016 | $1,211,000 | +5.2% | 24,765 | +36.3% | 0.04% | +15.8% |
| Q1 2016 | $1,151,000 | +94.1% | 18,176 | +243.8% | 0.04% | +100.0% |
| Q4 2015 | $593,000 | -46.7% | 5,287 | -54.3% | 0.02% | -42.4% |
| Q3 2015 | $1,113,000 | -79.8% | 11,561 | -78.5% | 0.03% | -76.4% |
| Q2 2015 | $5,500,000 | +61.1% | 53,712 | -2.3% | 0.14% | +62.8% |
| Q1 2015 | $3,414,000 | – | 54,981 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| First Light Asset Management, LLC | 437,512 | $31,772,000 | 2.80% |
| RTW INVESTMENTS, LP | 1,373,284 | $99,728,000 | 2.06% |
| Rock Springs Capital Management LP | 1,028,109 | $74,661,000 | 1.88% |
| Privium Fund Management B.V. | 112,727 | $8,186,000 | 1.81% |
| Avidity Partners Management LP | 869,000 | $63,107,000 | 1.31% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 525,100 | $38,133,000 | 1.16% |
| Boxer Capital, LLC | 200,000 | $14,524,000 | 0.75% |
| SECTOR GAMMA AS | 46,221 | $3,357,000 | 0.73% |
| FEDERATED HERMES, INC. | 3,987,728 | $289,589,000 | 0.65% |
| EMERALD ADVISERS, LLC | 223,952 | $16,263,000 | 0.62% |